Suchergebnisse - "Bone, Henry G"

PubPharm (100)

1

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism

enthalten in: Journal of the Endocrine Society | 2023

von Watts, N. | Bilezikian, J. | Bone, H. | +11

2

Abaloparatide : an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis

enthalten in: Current medical research and opinion | 2020

von Miller, P. | Bilezikian, J. | Fitzpatrick, L. | +4

3

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density : A Randomized, Double-Blind, Phase 2, Parallel Group Study

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2018

von McClung, M. | Brown, J. | Diez-Perez, A. | +10

CommentIn: Ann Transl Med. 2020 Aug;8(15):974. - PMID 32953774

4

ACTIVExtend : 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

enthalten in: The Journal of clinical endocrinology and metabolism | 2018

von Bone, H. | Cosman, F. | Miller, P. | +10

5

Denosumab treatment in postmenopausal women with osteoporosis - Authors' reply

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Bone, H. | Wagman, R. | Pannacciulli, N. | +1

CommentOn: Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. - PMID 28546097

6

Safety Observations With 3 Years of Denosumab Exposure : Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2017

von Watts, N. | Brown, J. | Papapoulos, S. | +8

7

10 years of denosumab treatment in postmenopausal women with osteoporosis : results from the phase 3 randomised FREEDOM trial and open-label extension

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Bone, H. | Wagman, R. | Brandi, M. | +17

CommentIn: Lancet Diabetes Endocrinol. 2017 Jul;5(7):485-487. - PMID 28546094

8

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

enthalten in: BMC musculoskeletal disorders | 2017

von Adachi, J. | Bone, H. | Daizadeh, N. | +9

9

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

enthalten in: BMC musculoskeletal disorders | 2017

von Adachi, J. | Bone, H. | Daizadeh, N. | +9

10

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

enthalten in: BMC musculoskeletal disorders | 2017

von Adachi, J. | Bone, H. | Daizadeh, N. | +9

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]